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Abstract
Ectopic ACTH syndrome is a rare cause of Cushing’s syndrome accounting for about 15% of all cases.
Small cell lung cancer and bronchial carcinoids account for about half of the cases. Malignant
neoplasm has rapid and more aggressive metabolic effects. We report a 54-year-old male patient with
phenotypic features of Cushing’s syndrome with severe hypokalemia, metabolic alkalosis,
hypertension and altered mental status as manifestations of an ACTH-secreting small cell carcinoma
from the lung. Ectopic ACTH syndrome should be highly considered in patients with hypertension
and severe hypokalemic metabolic alkalosis, especially when a lung mass is discovered.
Introduction
Certain tumors of non-endocrine tissues can give rise to
Cushing’s syndrome by secreting an adrenocorticotropic
substance, a concept that was proposed by Meador et al.
more than 50 years ago [1]. Ectopic ACTH secretion (EAS)
is a very rare cause of Cushing’s syndrome accounting for
about 15% of cases, and about 20% of ACTH-dependent
cases. Virtually all tumors have been associated with EAS,
however lung cancer (including small cell carcinoma and
bronchial carcinoids) accounts for half of the cases and
more than a quarter of the cases remains occult without
determining the source of the ectopic secretion [2].
DifferentiationbetweenthetwoformsofACTH-dependent
Cushing’s syndrome is a challenging task that requires a
well structured diagnostic work-up [3]. Duration of the
disease and glucocorticoid hormone levels are major
determinants in the clinical appearance of Cushing’s
syndrome. The type of tumor strongly influences the
clinical course: EAS by small cell carcinoma (SCC) and
other malignant neoplasms typically leads to early appear-
ance and more pronounced metabolic alterations. In
contrast, less aggressive tumors with a delayed diagnosis
show clinical characteristics similar to those of pituitary
Cushing’s syndrome [4]. Clinicians should be aware
that in a patient with rapidly progressive small cell lung
cancer (SCLC) and a deteriorating clinical condition; the
development of ectopic Cushing’s syndrome can pass
undiagnosed,leadingtosignificantadditionalcomorbidity
[5]. Hypertension with hypokalemia is a common finding
in many endocrinological disorders, including Cushing’s
syndrome. When a patient has a rapid deterioration in
clinical condition with severe metabolic alkalosis and
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We report a case of a Mexican mestizo man with
severe hypertension, hypokalemia, altered mental status
and severe metabolic alkalosis as presentations of EAS by
a small cell carcinoma from the lung.
Case presentation
A 54 year old Mexican mestizo man was admitted to the
Internal Medicine department of the Regional Hospital
Dr. “Valentín Gómez Farías” presenting with altered mental
status, paresthesias, hypokalemia, and severe hypertension.
The patient worked as a teacher. He was a 10 pack year
smokerfor45yearsandanoccasionaldrinker.Healsohasa
history of using cocaine and smoking marijuana. He lived a
sedentary life, and was obese since childhood, being unable
to lose weight with conventional diets. He had no family
history of cancer or surgical interventions.
The patient was in good health until three months before
admission when he presented with fatigue, intermittent
paresthesias of all limbs, cold intolerance, polyuria, weight
gain,andirritability.Heconsultedaprimarycarephysician
that made a diagnosis of diabetes mellitus, hypertension,
and dyslipidemia and began treatment with Metformin
850 mg twice daily, Glargine insulin 16 units in the
morning, Enalapril 10 mg twice daily, and Atorvastatin
20 mg at night. After one month, the patient discontinued
the Enalapril on his own. During the next few months
the patient presented with generalized edema, abdominal
striae, and depressive symptoms. Also two days before
admission he presented with confusion. On arrival, the
physicalexamfoundhimtobeobese,withplethoricfacies,
severe edema of the lower limbs, bruising and red-purple
abdominal striae (Figure 1). He was confused without any
signoffocalization orlateralization.Hisvitalsignsshowed
a blood pressure of 210/140 mmHg, heart rate of 62 beats
per minute, respiratory rate of 14 per minute, and
temperature of 37.2 degree Celsius. Blood biochemistry
results were as follows: hypokalemia of 1.8 mEq/L with
severe metabolic alkalosis (ph 7.59, HCO3 50.7, pO2 50,
Sat O2 90%), white cell count 5740/mmc, hemoglobin
13.1 g/dL, platelets 161,000/mmc, glucose 198 mg/dL,
creatinine 0.74 mg/dL, sodium 141 mEq/L, chloride
99 mEq/L, lactic dehydrogenase 702 U/L, ALT 26.7 U/L,
CPK 91 U/L, albumin 3.2 g/dL, PT 12 seconds (test
12.4 seconds) INR 0.95, urinary sodium 45.9 mmol/L,
urinary potassium 48.2 mmol/L, urine glucose +++, urinary
proteins +. The electrocardiogram showed a first degree AV
block. The lungs where clear under auscultation. The chest
X-ray showed an undefined nodular opacity in the hilar
region of the right lung (Figure 2). We started intravenous
administration of large amount of potassium chloride
(20 mEq per hour), intravenous insulin, and an intravenous
antihypertensive (sodium nitroprusside). Following the
treatment he experienced complete remission of mental
confusion, and improvement, however his blood pressure
did not normalize (150/100 mmHg). In view of these
findings a protocol for detecting endocrine hypertension
was followed, including tests for Cushing’ss y n d r o m ea n d
primary hyperaldosteronism. Forty-eight hours later
basal plasma renin activity and aldosterone were measured
and determined as normal. The respective values were
0.53 ng/ml/h (normal values between 0.2-2.8 ng/ml/h) and
52.5 pg/mL (normal values between 10-160 pg/mL). The
abdominal CT scan showed diffuse enlargement of the
adrenal glands without focal lesions, without any abnorm-
alities of the liver or spleen (Figure 3). The 24 hour free
cortisol urinary levels were 6600 μg( n o r m a lv a l u e s4 - 1 0 0
μg) using the immunoenzymatic method. The ACTH levels
were 107 pg/mL (normal values are less than 46 pg/mL), by
Figure 1. Abdominal stretch marks.
Figure 2. Chest X-ray showing a diffuse nodular opacity in
the hilar region of the right lung.
Page 2 of 5
(page number not for citation purposes)
Cases Journal 2009, 2:6174 http://casesjournal.com/casesjournal/article/view/6174thequimioluminiscencemethod.Highdosedexamethasone
suppression test (8 mg) showed suppression of approxi-
mately 8% of the cortisol serum levels. A brain CT scan,
including the sellar region was normal. These results,
together with the clinical and radiological findings support
the diagnostic hypothesis of ectopic ACTH-dependent
Cushing’ssyndrome.Thepatientpersistedwithhypokalemia
and hypertension, both of which could not be controlled
despite management with large dose of intravenous potas-
s i u m( u pt o2 4 0m E qp e rd a y )f o rt h eh y p o k a l e m i a ,a n d
Enalapril20mgstwicedaily,Telmisartan160mgfourtimes
daily, Felodipine 10 mgs twice daily, and Spironolactone
200 mg four times daily(once primaryhyperaldosteronism
was excluded) for the hypertension. The concentration
of tumor markers were as follows: alpha-fetoprotein of
3.8 ng/ml (normal values 0-15 ng/ml), carcinoembryonic
antigen of 2.6 ng/ml (normal values 0-5 ng/ml), and
serum glycoprotein CA 125 of 10.96 U/ml (normal values
0-35 U/ml). A chest CT scan showed a cavitated right lung
mass localized in the medial lobe of the anterior medial
segment and minimal pleural effusion (Figure 4A). We also
observedsomedegreeofpleuralthickening.Onday24aCT
guided fine-needle lung biopsy was performed, (Figure 4B)
showing histopathological results of a small cell neoplasm
(Figure5).Theinstabilityofthepatientdidnotallowforthe
initiation of chemotherapy, therefore treatment with
Ketoconazole 400 mgs was begun before initiating che-
motherapy. While waiting for the patient’s basal situation
to improve before starting chemotherapy, we started keto-
conazole 400 mgs twice daily with a rapid normalization of
blood pressure and potassium plasma levels. Seventy two
hours later the patient presented with sepsis due to a right
leg cellulitis that was treated with meropenem. Despite a
partial response to the medical treatment the patient
worsened and developed bilateral pleural effusions, and
respiratory failure that required assisted mechanical ventila-
tion dying a few days later.
Discussion
The case reported here was presented as a hypertensive
crisis associated with hypokalemia, severe metabolic
Figure 3. Abdominal CT scan showing diffuse enlargement
(hyperplasia) of the adrenal glands without focal lesions. No
metastatic lesions were observed in the liver and spleen. Also
there was not lymph node enlargement.
Figure 4. (A) Chest CT scan showing a cavitated right lung mass and right pleural effusion, (B) CT guided fine-needle lung
biopsy.
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initial symptoms are explained by the presence of
metabolic abnormalities due to severe hypercortisolism
(diabetes mellitus, hypertension and hypokalemia) but
the initial diagnosis was delayed due to poor clinical
suspicion and a high prevalence of diseases such as
diabetes and hypertension in Mexico. The rapid deteriora-
tion of his health, and some cushingoid characteristics,
strongly suggested that the clinical symptoms were
secondary to some cause of Cushing’s syndrome [5].
Cortisol increases the blood pressure by multiple mechan-
isms. The high blood pressure upon arrival (due to his
poor adherence to treatment and hypercortisolism) and
the metabolic abnormalities explain the neurological
symptoms like confusion seen in this case. Once the
bloodpressure of thepatient decreased,andlarge amounts
of potassium were administrated, a rapid improvement in
his neurological status was observed. However, the patient
continued to demonstrate minor depressive symptoms
(mainly apathy, hypersomnia, irritability, and hopeless
thoughts). In patients with EAS, psychiatric symptoms are
frequently reported in about 50% of cases. The most
frequent are depression and psychosis [6]. Although
the association of hypertension and hypokalemia are
often attributed to primary hyperaldosteronism, the
normal levels of plasma renin activity and aldosterone are
opposed in this diagnosis. But in view of the mineralocorti-
coid action of high cortisol concentrations, other causes
should be considered. The local cortisol conversion to
cortisone by the action of 11 beta-hydroxysteriod dehy-
drogenase is the rate-limiting step for the mineralocorticoid
effect of cortisol under normal conditions. When plasma
concentrations of cortisol are very high, the action of this
enzymeisinsufficient(themineralocorticoidescapepheno-
menon) and mineralocorticoid effects appear [2]. The
elevated levels of ACTH, free urinary cortisol excretion,
a positive high dexamethasone suppression test and the
hilar opacity observed in chest X-ray strongly suggested
that the clinical symptoms were due to a malignant ACTH
secreting neoplasm.
The gold standard for the differential diagnosis of pituitary
and ectopic ACTH-dependent Cushing’s syndrome is the
bilateral inferior petrosal sinus sampling after adminis-
tration of CRH (1 μg/kg). A ratio greater than 3.0 after
the administration of CRH is consistent with Cushing’s
disease. Patients with EAS will have a ratio less than
2 before and after CRH administration because the
endogenous hypercortisolism suppresses pituitary ACTH
release through negative feedback mechanisms (sensitivity
97%, specificity 100%). High-dose dexamethasone sup-
pression tests have lower sensitivity (81%) and specificity
(67%) [3]. In this case, the rapid clinical course did not
permit pituitary magnetic resonance imaging or the tests
generally considered as gold standards for ectopic ACTH-
dependent Cushing’s syndrome (although the CT scan
from the sellar region did not reveal visible lesions).
Nevertheless, we can establish this diagnosis with high
probability, since this patient’s Cushing’s syndrome was
ACTH-dependent, with a positive result in the high-dose
dexamethasone suppression test with characteristic phe-
notype and biochemical presentation (hypertension and
severe hypokalemic metabolic alkalosis), and with a
tumor type that can cause Cushing’s syndrome.
The SCLC is a well recognized origin of EAS. The incidence
of SCLC is about 13% of all newly diagnosed lung cancers
in Mexico [7], and patients with extensive disease have
median survival duration of 6 weeks. The course seen in
the present case is in line with this view. Although there are
few cases of EAS reported in Mexico, the longest series of
reported cases (8 patients) the lung was traced as the
source with bronchial carcinoids being diagnosed in half
[8]. Because the patient’s rapid deterioration no more
diagnostic studies were performed. An autopsy was not
performed.
Ketoconazole has been used to treat Cushing’s syndrome
by inhibiting adrenal glucocorticoid synthesis. Treatment
with ketoconazole promotes a palliative hormonal
response in more than 50% of patients [9]. In this patient,
ketoconazole (400 mg twice daily) promoted a rapid
resolution of hypokalemia and hypertension. Due to a
rapid clinical deterioration, the patient was not able to
receive standard chemotherapy with carboplatin and
etoposide for SCLC [10].
Figure 5. Photomicrography of the histology of the lung mass
biopsy specimen (100×) showing atypical small cells with
sparse acidophil cytoplasm, lobulated and rounded nuclei, and
compact chromatin.
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Ectopic ACTH syndrome is a rare cause of ACTH-
dependent Cushing syndrome. Nearly any neuroendo-
crine or non endocrine tumor may be associated with EAS.
In advanced tumors the features of hypercortisolism may
be masked by a general deterioration in clinical condition
and interpreted as a progression of the neoplastic disease.
Failure to recognize EAS can carry additional morbidity.
EAS requires a well established diagnostic work up, and
must be considered strongly in patients with hypertension
and severe hypokalemic metabolic alkalosis especially
when a lung mass is discovered.
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